Human Mixtard 50 Injection 40IU/ml
Marketer
Novo Nordisk India Pvt Ltd
Salt Composition
Insulin Isophane (50%) + Human insulin (50%)
Overview Human Mixtard 50 Injection 40IU/ml
Insulin Human Mixtard 50 Injection (40 IU/mL) combines fast- and intermediate-acting insulins to manage blood glucose in adults and children with type 1 or type 2 diabetes. This medication aids in maintaining blood sugar levels, typically used alongside other diabetes treatments as directed by your healthcare provider. Proper subcutaneous injection technique will be demonstrated by your doctor or nurse. Administer 15 minutes prior to or within 20 minutes post-meal. Discontinue use only under medical supervision. Effective diabetes management necessitates a holistic approach, including diet, exercise, and weight management as recommended by your physician. Regular blood glucose monitoring and result reporting are crucial for dose optimization. Hypoglycemia (low blood sugar) is a frequent side effect; consistent dosing, regular meals, and glucose monitoring are key preventative measures. Excessive alcohol intake increases hypoglycemia risk. Injection site reactions (redness, swelling) may occur. Weight gain, rash, edema, and itching are also possible. Avoid use during hypoglycemic episodes. Inform your doctor of any pre-existing kidney, liver, or heart conditions before commencing treatment. Pregnant or breastfeeding individuals require specific dosage consultation.
Primary Ingredients of Human Mixtard 50 Injection 40IU/ml
No information provided. Please provide the text you wish me to rephrase.
Uses of Human Mixtard 50 Injection 40IU/ml
Managing Diabetes Mellitus
Major Benefits of Human Mixtard 50 Injection 40IU/ml:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Human Mixtard 50 Injection 40IU/ml:
- Hypoglycemia (low blood glucose level)
- Injection site reactions (pain, swelling, redness)
- Weight gain
How to use Human Mixtard 50 Injection 40IU/ml:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Human Mixtard 50 Injection 40IU/ml works:
Isophane insulin provides sustained glycemic control, whereas regular human insulin offers a swift onset. Their combined action delivers prompt and stable blood glucose management through enhanced glucose uptake in adipose and muscle tissues and reduced hepatic glucose production.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Human Mixtard 50 Injection 40IU/ml is dangerous.
PregnancySAFE IF PRESCRIBED
The injectable medication, Human Mixtard 50 (40 IU/mL), is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Human Mixtard 50 Injection (40 IU/ml) while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Human Mixtard 50 Injection (40 IU/ml). Dosage modification of Human Mixtard 50 Injection (40 IU/ml) might be necessary. Physician consultation is advised. Routine blood glucose monitoring is recommended to guide dosage changes.
LiverCAUTION
Individuals with hepatic impairment should use Human Mixtard 50 Injection 40IU/ml cautiously. Dosage modification of Human Mixtard 50 Injection 40IU/ml may be necessary; physician consultation is advised.
What if you forget to take Human Mixtard 50 Injection 40IU/ml :
Delayed administration of your Human Mixtard 50 Injection 40IU/ml may lead to elevated blood glucose (hyperglycemia). Monitor your blood sugar and adjust your subsequent dose as needed.
Facts to Know About Human Mixtard 50 Injection 40IU/ml
Label | Value |
---|---|
Developing Habits | No. |
Treatment Category | Diabetes Management |